Please wait while the formulary information is being retrieved.
NUVESSA (METRONIDAZOLE)
- Bacterial vaginosis
1.3 % vaginal gel
- Insert 1 applicatorful (65 mg) by vaginal route once at bedtime
Bacterial vaginosis
- Insert 1 applicatorful (65 mg) by vaginal route once at bedtime
- Antabuse
- Dehydrated Alcohol
- Desenex
- disulfiram
- Ery Pads
- Erygel
- erythromycin with ethanol
- ethanol (ethyl alcohol)
- ethyl alcohol-herbal drugs
- foot deodorant comb. no.1
- Lydia Pinkham Herbal
- typhoid vaccine
- Vivotif Berna Vaccine
Contraindicated
- busulfan
- Coumadin
- Jantoven
- Myleran
- warfarin
Severe
Moderate
- Alagesic Lq
- amobarbital
- Amytal
- Ascomp With Codeine
- Belladonna-phenobarbital
- Bupap
- butabarbital
- Butalbital Compound W/codeine
- Butalbital Compound-codeine
- butalbital-acetaminop-caf-cod
- butalbital-acetaminophen
- butalbital-acetaminophen-caff
- butalbital-aspirin-caffeine
- Butisol
- Capacet
- codeine-butalbital-ASA-caff
- Donnatal
- Esgic
- Fioricet
- Fioricet With Codeine
- Fiorinal
- Fiorinal-codeine #3
- Luminal
- Margesic
- Marten-tab
- Mysoline
- Nembutal Sodium
- pentobarbital sodium
- phenobarb-hyoscy-atropine-scop
- phenobarbital
- phenobarbital sodium
- primidone
- secobarbital sodium
- Seconal Sodium
- Tencon
- Zebutal
- None
Contraindicated
- Alcohol intoxication
- Alcoholism
- Lower seizure threshold
- Non-infective meningitis
- Peripheral neuropathy
- Seizure disorder
Severe
Moderate
- Severe hepatic disease
NUVESSA (METRONIDAZOLE)
- Bacterial vaginosis
- None
- Diarrhea
- Dysmenorrhea
- Genital organ pruritus
- Headache disorder
- Nausea
- Vulvovaginal candidiasis
More Frequent
Severe
Less Severe
- Abdominal pain with cramps
- Increased urinary frequency
- Alcohol intolerance
- Anorexia
- Dizziness
- Dysgeusia
- Vaginitis
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Dyspareunia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Metronidazole (Vag)
No safety and efficacy data established pre-menarche.
- 1 Day – 11 Years
- No safety and efficacy data established pre-menarche.
Metronidazole
- Severity Level:
2
- Additional Notes: Crosses placenta; recom when alternate treatment inadequate; insuff human data
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Metronidazole (topical, Vaginal)
Serum levels of topical form minimal, effects to infant unknown.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Serum levels of topical form minimal, effects to infant unknown. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Bacterial vaginosis | |
| N76.0 | Acute vaginitis |
| 0-9 | A-Z |
|---|---|
| N76.0 | Acute vaginitis |
Formulary Reference Tool